Treatment of Prostate Cancer With Fucoidan of Low Molecular Weights in Combination With Guanine-rich Oligonucleotide Therapy
Three oncogenes, ErbB receptors, Ras proteins and nucleolin, may contribute to malignant transformation of healthy cells. Previously, mutant Ras was shown to be capable of activating ErbB receptors in a ligand-independent manner. Moreover, nucleolin, a transcriptional regulator and ribosome biogenes...
| Main Author: | |
|---|---|
| Other Authors: | , |
| Format: | Others |
| Published: |
Auckland University of Technology,
2017-08-30T23:55:12Z.
|
| Subjects: | |
| Online Access: | Get fulltext |